Clinical trial
Multicentric, Prospective, Randomized Controlled Trial Comparing Best Systemic Therapy (BST) With Radical Prostatectomy or BST Alone in the Management of Men With Pauci-metastatic Prostate Cancer
NCT02454543 is registered in ClinicalTrials.gov with Martini-Klinik am UKE GmbH as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Multicentric, Prospective, Randomized Controlled Trial Comparing Best Systemic Therapy (BST) With Radical Prostatectomy or BST Alone in the Management of Men With Pauci-metastatic Prostate Cancer
- Lead sponsor
- Martini-Klinik am UKE GmbH
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- May 31, 2015
- Completion date
- December 31, 2026
- Enrollment
- 452 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
prostate cancer